Skip to Content

Angiomax

In the US, Angiomax (bivalirudin systemic) is a member of the drug class thrombin inhibitors and is used to treat Angina and Percutaneous Coronary Intervention.

US matches:

Ingredient matches for Angiomax

Bivalirudin

Bivalirudin is reported as an ingredient of Angiomax in the following countries:

  • Argentina
  • Canada
  • Chile
  • Israel
  • United States

Bivalirudin trifluoroacetate (a derivative of Bivalirudin) is reported as an ingredient of Angiomax in the following countries:

  • New Zealand

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide